Belpointe Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18	Closed	-$652	–	3044
2023 Q1	$652	Buy	+18	New	+$652	﹤0.01%	3560